{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:31:54Z","timestamp":1758403914907},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.atherosclerosis.2009.04.036","type":"journal-article","created":{"date-parts":[[2009,5,5]],"date-time":"2009-05-05T08:35:10Z","timestamp":1241512510000},"page":"84-92","source":"Crossref","is-referenced-by-count":19,"title":["A meprin inhibitor suppresses atherosclerotic plaque formation in ApoE\u2212\/\u2212 mice"],"prefix":"10.1016","volume":"207","author":[{"given":"Pan","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib1","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1074\/jbc.M208808200","article-title":"Structure of homo- and hetero-oligomeric meprin metalloproteases. Dimers, tetramers, and high molecular mass multimers","volume":"278","author":"Bertenshaw","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1515\/BC.2002.129","article-title":"Probing the active sites and mechanisms of rat metalloproteases meprin A and B","volume":"383","author":"Bertenshaw","year":"2002","journal-title":"Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0888-7543(95)80142-9","article-title":"The structural genes, MEP1A and MEP1B, for the alpha and beta subunits of the metalloendopeptidase meprin map to human chromosomes 6p and 18q, respectively","volume":"25","author":"Bond","year":"1995","journal-title":"Genomics"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib4","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1128\/MCB.23.4.1221-1230.2003","article-title":"Targeted disruption of the meprin beta gene in mice leads to underrepresentation of knockout mice and changes in renal gene expression profiles","volume":"23","author":"Norman","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/abbi.2001.2672","article-title":"Chaperone interactions of the metalloproteinase meprin A in the secretory or proteasomal-degradative pathway","volume":"397","author":"Tsukuba","year":"2002","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib6","first-page":"1515","article-title":"Metalloendopeptidases of the mouse kidney brush border: meprin and endopeptidase-24.11","volume":"45","author":"Bond","year":"1986","journal-title":"Biomed Biochim Acta"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1432-1033.1991.tb16219.x","article-title":"A membrane-bound metallo-endopeptidase from rat kidney hydrolyzing parathyroid hormone. Purification and characterization","volume":"200","author":"Yamaguchi","year":"1991","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1432-1033.1992.tb16666.x","article-title":"A membrane-bound metallo-endopeptidase from rat kidney. Characteristics of its hydrolysis of peptide hormones and neuropeptides","volume":"204","author":"Yamaguchi","year":"1992","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bj2550045","article-title":"The metabolism of neuropeptides. Hydrolysis of peptides by the phosphoramidon-insensitive rat kidney enzyme \u2018endopeptidase-2\u2019 and by rat microvillar membranes","volume":"255","author":"Stephenson","year":"1988","journal-title":"Biochem J"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0008-6363(01)00327-3","article-title":"Molecular biology of natriuretic peptides and nitric oxide synthases","volume":"51","author":"Kone","year":"2001","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1471-4892(02)00142-X","article-title":"B-type natriuretic peptide for the treatment of congestive heart failure","volume":"2","author":"Schreiner","year":"2002","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib12","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.107.153585","article-title":"Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide","volume":"101","author":"Pankow","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0306-3623(96)00275-3","article-title":"Effects of natriuretic peptides on vascular smooth-muscle cells derived from different vascular beds","volume":"28","author":"Arjona","year":"1997","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11010-005-4779-0","article-title":"Role of atrial natriuretic peptide in the suppression of lysophosphatydic acid-induced rat aortic smooth muscle (RASM) cell growth","volume":"272","author":"Baldini","year":"2005","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1023\/A:1025508828271","article-title":"Oxidant-induced pHi\/Ca2+ changes in rat aortic smooth muscle cells. The role of atrial natriuretic peptide","volume":"252","author":"De Vito","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardiores.2006.08.012","article-title":"Intracellular peptides of natriuretic peptide receptor-C inhibit vascular hypertrophy via Gqalpha\/MAP kinase signaling pathways","volume":"72","author":"Li","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib17","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S0735-1097(99)00593-8","article-title":"Vascular actions of brain natriuretic peptide: modulation by atherosclerosis and neutral endopeptidase inhibition","volume":"35","author":"Schirger","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cardiores.2006.03.019","article-title":"Vascular neutral endopeptidase inhibition improves endothelial function and reduces intimal hyperplasia","volume":"71","author":"Barber","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib19","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1161\/ATVBAHA.107.156257","article-title":"IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice","volume":"27","author":"Sukhanov","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib20","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/01.ATV.0000071702.45741.2E","article-title":"Increased atherosclerosis and smooth muscle cell hypertrophy in natriuretic peptide receptor A\u2212\/\u2212apolipoprotein E\u2212\/\u2212 mice","volume":"23","author":"Alexander","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib21","first-page":"171","article-title":"Antitumor activity of actinonin in vitro and in vivo","volume":"4","author":"Xu","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib22","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.bjp.0705354","article-title":"Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice","volume":"139","author":"Jiang","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000095309","article-title":"Apolipoprotein E knockout mice over-expressing human tissue inhibitor of metalloproteinase 1 are protected against aneurysm formation but not against atherosclerotic plaque development","volume":"43","author":"Cuaz-Perolin","year":"2006","journal-title":"J Vasc Res"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/res.90.3.251","article-title":"Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly","volume":"90","author":"Galis","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9440(10)63114-8","article-title":"Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries","volume":"164","author":"Cheng","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1172\/JCI200314915","article-title":"Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice","volume":"111","author":"Sukhova","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nm1095-1067","article-title":"Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta","volume":"1","author":"Grainger","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib28","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1161\/01.RES.0000041036.86977.14","article-title":"Targeted disruption of the matrix metalloproteinase-9 gene impairs smooth muscle cell migration and geometrical arterial remodeling","volume":"91","author":"Galis","year":"2002","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2741\/1803","article-title":"Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase","volume":"11","author":"Lincoln","year":"2006","journal-title":"Front Biosci"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib30","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/dna.2004.23.586","article-title":"Natriuretic peptide gene expression after beta-adrenergic stimulation in adult mouse cardiac myocytes","volume":"23","author":"Ander","year":"2004","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI117367","article-title":"Gene expression and secretion of atrial natriuretic peptide by murine macrophages","volume":"94","author":"Vollmar","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000159030","article-title":"Cyclic-GMP-mediated decrease in permeability of human umbilical and pulmonary artery endothelial cell monolayers","volume":"31","author":"Westendorp","year":"1994","journal-title":"J Vasc Res"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1006\/bbrc.1994.2731","article-title":"Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells","volume":"205","author":"Wei","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1472-8206.2005.00336.x","article-title":"Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology","volume":"19","author":"Houben","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.regpep.2008.02.009","article-title":"Brain natriuretic peptide (BNP) regulates the production of inflammatory mediators in human THP-1 macrophages","volume":"148","author":"Chiurchiu","year":"2008","journal-title":"Regul Pept"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib36","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cardiores.2006.07.006","article-title":"Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes","volume":"72","author":"Laskowski","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2009.04.036_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.RES.0000151983.01148.06","article-title":"Atrial natriuretic peptide induces mitogen-activated protein kinase phosphatase-1 in human endothelial cells via Rac1 and NAD(P)H oxidase\/Nox2-activation","volume":"96","author":"Furst","year":"2005","journal-title":"Circ Res"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009003311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915009003311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T21:15:07Z","timestamp":1558300507000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915009003311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0021915009003311"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.04.036","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}